HBV Mutation Detail Information

> M204V Search Result


Mutation Information
Mutation Site M204V
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Combined Mutation rt.L180M+rt.M204V+rt.I233V;rt.V173L+rt.L180M+rt.M204V+rt.M204I+rt.I233V
Relevant Drug lamivudine (LAM)
Country China
Literature Information
PubMed PMID 26079809
Disease HBV infection
Published Year 2016
Journal Antiviral therapy
Title Increased occurrence of mutant rtI233V of HBV in patients receiving adefovir therapy.
Author Liu Y,Xin S,Ye X,Chen R,Xu Z,Li X,Ye H,Cheng S,Xu D
Evidence Direct sequencing showed that rtI233V substitution emerged alone in 33 patients, in conjunction with LAM-resistant mutation (rtA181V, rtN236T) in 9 patients, and in conjunction with LAM-resistant mutation (rtM204I, rtM204V) in 4 patients who had experienced LAM prior to ADV treat-ment (Table 1).

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation